27
Participants
Start Date
August 8, 2012
Primary Completion Date
April 3, 2018
Study Completion Date
April 3, 2018
Cerenkov emissions from the PET tracer 18F-FDG and the radiotherapeutic 131I
We will image (i) patients who are receiving a PET/CT scan for tumors in the head / neck region and (ii) patients with thyroid cancer after 131I radioablation. Two scans will be completed per patient, one of the primary tumors, as well as a 'background' scan of the contralateral side or, if tumor is there as well, of the forearm. The device to be used is an intensified charge-coupled device camera (Stanford Photonics, Palo Alto, CA) connected to a laptop PC. The camera will use a Quartz high-UV transmission 50 mm 0.8f lens. The Imaging device will be placed approximately 5 cm from the area of the patient to be imaged.
Memorial Sloan-Kettering Cancer Center, New York
National Institutes of Health (NIH)
NIH
Memorial Sloan Kettering Cancer Center
OTHER